your resource for all things leadership in life sciences
A podcast to share the tools, tips, tricks and routines of top biotech executives in order to help develop the next generation of life science industry leaders and expedite the launch of new therapies to transform the lives of patients all over the world.
Latest Episodes
In this episode of The Phase 3 Biotech Leadership Podcast, we are joined by Bob Ferrigno, Sr. Vice President of Global Sales and Marketing at SynergEyes, who shared insights from his extensive career in the biotech industry, focusing on leadership, team-building, and career development. Bob discusses his assertive career management at Becton Dickinson, where he held 15 different positions over 32 years, and his experiences working in various geographical markets. The conversation delves into his strategies for managing without authority, the importance of psychological safety, and how to drive success in both large and small companies.
Learn from Bob’s journey as he explains his approach to profiling, strategic planning, and navigating the complexities of business leadership.
In this episode of the Phase 3 Biotech Leadership Podcast, we sit down with Dan Couto, Chief Operating Officer of Vedanta Biosciences, to explore the critical role of mastering change in biotech leadership.
Dan shares his diverse experiences across the biotech sector, highlighting key leadership skills such as problem-solving, effective communication, and relationship-building. Tune in for a wealth of knowledge on becoming a dynamic and adaptive leader in biotech.
Did you know that only 2.5% to 3% of venture capital dollars go to female-founded companies, especially those led by women of color?
In this brand new season of The Phase 3 Leadership Podcast, we’re kicking things off with an eye opening episode featuring special guest Shawnte Mitchell. Shawnte delves into this startling statistic and shares her involvement with How Women Invest, an initiative by Julie Castro Abrams to help women gain access to venture capital and investment opportunities.
Our expert panel of C-level executives and board members reveal their tips tricks for successful late stage funding rounds. Great insight from:
- Hari Pujar – Operating Partner at Flagship Therapeutics and COO at Tessera Therapeutics
- Randy Berholtz – Chair and Chief Executive Officer Chair and Chief Executive Officer – Rancho Santa Fe Bio, Inc.
- Kameel Farag – CFO Aspen NeuroScience
Our expert panel of hugely successful biotech C-leaders jump into best practices to ensure successful early fund raises in the biotech space. Having raised 100’s of millions of dollars between them this is a great listen for all of those joining the fundraising roadshow.
- Doug Carlson – Chief Operating and Financial Officer – Avenge Bio
- Mike Tusche – Co-CEO – Treadwell Therapeutics
- Brian McVeigh – CEO – Code Biotherapeutics
Interested in becoming a guest?
We’re always looking for fresh perspectives from industry thought leaders. If you would like to join us for an upcoming episode, please submit your information for consideration using the form below.
